27th October 2016
Daniel Barton spoke with Fintan Walton of Pharmaventures about the Biosceptre portfolio while attending the Sachs Associates 16th Annual Biotech in Europe Conference in Basel Switzerland.
Daniel Barton spoke with Fintan Walton of Pharmaventures about the Biosceptre portfolio while attending the Sachs Associates 16th Annual Biotech in Europe Conference in Basel Switzerland.